Survival, Morbidities, and Developmental Outcomes among Low Birth Weight Infants with Congenital Heart Defects

Mihai Puia-Dumitrescu1, Laura N Sullivan2, David Tanaka3

  • 1Department of Pediatrics, University of Washington, Seattle, Washington.

Insights

Survival rates for low birth weight infants with congenital heart defects (CHDs) vary by birth weight and diagnosis. While overall survival improved, nearly half showed developmental delays at two years, particularly in language. This highlights the need for specialized care.

Area of Science:

  • Neonatal Medicine
  • Pediatric Cardiology
  • Developmental Pediatrics

Background:

  • Prematurity and low birth weight (LBW) are significant risk factors for increased morbidity and mortality in infants diagnosed with congenital heart defects (CHDs).
  • Understanding the outcomes of LBW infants with CHDs is crucial for improving clinical management and long-term prognosis.

Purpose of the Study:

  • To describe survival rates, in-hospital morbidities, and 2-year neurodevelopmental outcomes in infants with low birth weight (LBW) and congenital heart defects (CHDs).
  • To analyze the prevalence of CHD in relation to birth weight and gestational age.
  • To identify factors influencing in-hospital morbidities and mortality in this vulnerable population.

Main Methods:

  • Retrospective analysis of 420 infants with congenital heart defects (CHD) and birth weight (BW) <2,500g admitted to a level-IV NICU between January 2013 and March 2016.
  • Data collected included CHD prevalence by BW and gestational age, in-hospital morbidities, mortality, surgical interventions, and neurodevelopmental outcomes assessed using Bayley's Scales of Infant and Toddler Development, Third Edition (BSID-III) at 2 years.
  • Survival rates were analyzed based on BW, CHD type, and surgical status.

Main Results:

  • Overall survival to discharge was 88%, but lower in extremely LBW infants (<1,000g) at 81% and those undergoing surgery at 79%.
  • Common comorbidities included retinopathy of prematurity and bronchopulmonary dysplasia (35% prevalence).
  • At 2 years, 49% of assessed infants had BSID-III scores below 85, with language development being most commonly affected.

Conclusions:

  • Hospital mortality in low birth weight (LBW) infants with congenital heart disease (CHD) is influenced by birth weight and specific cardiac diagnoses.
  • Overall survival rates in this cohort were higher than previously reported, and morbidities were less frequent than anticipated.
  • A significant proportion of LBW infants with CHD experience neurodevelopmental challenges, particularly affecting language, by age 2, underscoring the need for early intervention.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
254
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.1K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
268
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
214
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.5K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
575